Citations 21

Early Adoption of Suzetrigine After FDA Approval: Inpatient and Outpatient Practice Patterns

Anesthesia & Analgesia | July 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1213/ane.0000000000008223 | PMID 42442349

Analysis of Tined Versus Internally Cooled Radiofrequency Ablation Needles for Chronic Sacroiliac Joint Pain (P7-14.010)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215313

Changes in the clinical backgrounds of pain medicine fellows in ACGME-accredited programs, 2020–2024

Regional Anesthesia & Pain Medicine | May 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: rapm-2026-107786

10.1136/rapm-2026-107786 | PMID 42082258

Autologous conditioned plasma is not platelet-rich plasma

Regional Anesthesia & Pain Medicine | February 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: rapm-2026-107629

10.1136/rapm-2026-107629 | PMID 41672585

ASRA Pain Medicine Consensus Practice Infection Control guidelines

Regional Anesthesia & Pain Medicine | July 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-106770

10.1136/rapm-2025-106770 | PMID 40695539

Reply to: Comment on: Guidelines for use and safety of corticosteroid injections in joints and musculoskeletal soft tissue

Regional Anesthesia & Pain Medicine | May 24, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-106815

10.1136/rapm-2025-106815 | PMID 40412820

Response to negative pressure wound therapy for infection control

Regional Anesthesia & Pain Medicine | April 18, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-106663

10.1136/rapm-2025-106663 | PMID 40250978

The association between chronic pain and metabolic syndrome: A scoping review

PM&R | March 15, 2025 | Volume: 17 | Issue: 9 | Pages: 1107-1119

10.1002/pmrj.13361 | PMID 40088147

AbstractMetabolic syndrome (MetS) is a prevalent comorbidity in patients with chronic pain conditions. Emerging evidence suggests that the relationship between MetS and chronic pain is bidirectional. This interplay involves complex mechanisms, including proinflammatory mediators in nociceptive modulation and pain‐induced lifestyle changes affecting metabolic function. This scoping review examines the association between MetS and chronic pain. We conducted a scoping review, including 28 studies. This review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses Extension for Scoping Reviews guidelines. We included observational studies (cross‐sectional, case–control, and cohort studies) from the following databases: Ovid MEDLINE, EMBASE, Cochrane Central, Cochrane Database of Systematic Reviews, and Scopus. We identified studies on migraine (n = 9), spinal pain (n = 8), general chronic pain (n = 4), fibromyalgia syndrome (n = 3), carpal tunnel syndrome (n = 1), osteoarthritis (n = 1), shoulder pain (n = 1), and neuropathic pain (n = 1). Most studies used a cross‐sectional design and standard criteria to define MetS, with some exceptions. Individuals with MetS and spinal pain, fibromyalgia, or general chronic pain showed higher pain scores and increased functional limitations. MetS was common in patients with migraine, but its effect on pain severity was inconclusive. The relationship between MetS and other pain conditions requires further investigation to clarify the association and potential mechanisms. MetS is prevalent in patients with chronic pain and is associated with worse pain and functional outcomes. Health care providers should acknowledge the wide spectrum of MetS beyond obesity. This understanding may help identify those at risk for more severe chronic pain.
ASRA Pain Medicine consensus practice infection control guidelines for regional anesthesia and pain medicine

Regional Anesthesia & Pain Medicine | January 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2024-105651

10.1136/rapm-2024-105651 | PMID 39837579

Background To provide recommendations on risk mitigation, diagnosis and treatment of infectious complications associated with the practice of regional anesthesia, acute and chronic pain management. Methods Following board approval, in 2020 the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) commissioned evidence-based guidelines for best practices for infection control. More than 80 research questions were developed and literature searches undertaken by assigned working groups comprising four to five members. Modified US Preventive Services Task Force criteria were used to determine levels of evidence and certainty. Using a modified Delphi method, >50% agreement was needed to accept a recommendation for author review, and >75% agreement for a recommendation to be accepted. The ASRA Pain Medicine Board of Directors reviewed and approved the final guidelines. Results After documenting the incidence and infectious complications associated with regional anesthesia and interventional pain procedures including implanted devices, we made recommendations regarding the role of the anesthesiologist and pain physician in infection control, preoperative patient risk factors and management, sterile technique, equipment use and maintenance, healthcare setting (office, hospital, operating room), surgical technique, postoperative risk reduction, and infection symptoms, diagnosis, and treatment. Consensus recommendations were based on risks associated with different settings and procedures, and keeping in mind each patient’s unique characteristics. Conclusions The recommendations are intended to be multidisciplinary guidelines for clinical care and clinical decision-making in the regional anesthesia and chronic interventional pain practice. The issues addressed are constantly evolving, therefore, consistent updating will be required.
Social media users’ perspectives of spinal cord stimulation: an analysis of data sourced from social media

Regional Anesthesia & Pain Medicine | October 25, 2024 | Volume: 51 | Issue: 1 | Pages: 25-32

10.1136/rapm-2024-105935 | PMID 39455090

Objectives To identify Reddit users’ viewpoints and inquiries about spinal cord stimulation (SCS) for chronic back pain using Reddit databases. Methods We performed a qualitative analysis of public, anonymous threads and comments from targeted subreddits within the Reddit community. We used the Python Reddit API Wrapper to extract relevant data. A qualitative descriptive approach was employed, using natural language processing to identify and categorize common questions, concerns, and opinions shared by patients regarding SCS. Results Our analysis included 112 posts and 448 comments. The tone of comments was neutral (n=231), followed by negative (n=121) and positive (n=96). 13 users actively encouraged other users to try the procedure, while 25 advised against it. The main topics of discussions revolved around pain relief expectations and adverse events. Almost half of users commenting about pain relief expectations reported experiencing considerably lower improvement than anticipated. Pocket pain, lead fracture/migration, infection risk, and scars were common topics of discussion among users. Furthermore, users shared strategies to mitigate postoperative discomfort and offered insights into device selection based on MRI conditionality, reprogramming need, and charging prerequisites. Conclusion Our Reddit analysis identified potential targets for enhanced dialog between physicians and patients around anticipated pain relief, complications, and postoperative care. Reddit and other social media platforms may offer valuable opportunities for healthcare professionals to improve engagement with patients.